Fuller & Thaler Asset Management
PACB icon

Fuller & Thaler Asset Management’s Pacific Biosciences PACB Stock Holding History

Fuller & Thaler Asset Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-271,384
Closed -$1.47M – 478
2018
Q3 		$1.47M Hold
271,384
– – 0.02% 321
2018
Q2 		$963K Hold
271,384
– – 0.01% 332
2018
Q1 		$556K Sell
271,384
-20,300
-7% -$52.7K 0.01% 348
2017
Q4 		$770K Sell
291,684
-93,655
-24% -$328K 0.01% 330
2017
Q3 		$2.02M Sell
385,339
-1,900
-0.5% -$8.17K 0.02% 244
2017
Q2 		$1.38M Sell
387,239
-1,500
-0.4% -$6.05K 0.02% 260
2017
Q1 		$2.01M Hold
388,739
– – 0.03% 213
2016
Q4 		$1.48M Hold
388,739
– – 0.02% 226
2016
Q3 		$3.48M Sell
388,739
-11,900
-3% -$99.5K 0.06% 162
2016
Q2 		$2.82M Hold
400,639
– – 0.05% 167
2016
Q1 		$3.4M Sell
400,639
-127,800
-24% -$1.26M 0.07% 148
2015
Q4 		$6.94M Buy
528,439
+25,000
+5% +$224K 0.15% 114
2015
Q3 		$1.84M Buy
503,439
+400
+0.1% +$1.96K 0.05% 204
2015
Q2 		$2.9M Buy
503,039
+10,500
+2% +$60.8K 0.08% 174
2015
Q1 		$2.88M Sell
492,539
-1,600
-0.3% -$11K 0.09% 182
2014
Q4 		$3.87M Buy
494,139
+7,400
+2% +$47.4K 0.14% 156
2014
Q3 		$2.39M Sell
486,739
-100
-0% -$523 0.1% 183
2014
Q2 		$3.01M Sell
486,839
-66,861
-12% -$335K 0.13% 175
2014
Q1 		$2.96M Sell
553,700
-65,000
-11% -$411K 0.14% 178
2013
Q4 		$3.24M Sell
618,700
-15,900
-3% -$73K 0.18% 170
2013
Q3 		$3.5M Sell
634,600
-9,500
-1% -$33K 0.21% 162
2013
Q2 		$1.63M Buy
+644,100
New +$1.6M 0.11% 216

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fuller & Thaler Asset Management's PACB Position: Q4 2018 in Review

Fuller & Thaler Asset Management sold out of Pacific Biosciences (PACB) in Q4 2018, closing a stake of 271,384 shares — an estimated $1.47M sold.

Fuller & Thaler Asset Management first reported a position in PACB in Q2 2013 and held it in 22 quarters. The position peaked at $6.94M in Q4 2015. 155 funds tracked by Wall St. Rank hold PACB as of Q4 2018.

  • Fuller & Thaler Asset Management reported no remaining Pacific Biosciences position as of Q4 2018 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 271,384 Pacific Biosciences shares in Q4 2018, an estimated $1.47M.
  • Fuller & Thaler Asset Management first reported a position in Pacific Biosciences in Q2 2013 and held it in 22 quarters.
  • Fuller & Thaler Asset Management's Pacific Biosciences position peaked at $6.94M in Q4 2015.
  • 155 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2018.

Based on Fuller & Thaler Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.